rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2003-11-12
|
pubmed:abstractText |
The use of hydroxychloroquine (HCQ) in pregnancy remains controversial. The recent demonstration that HCQ passes across the placenta, with cord blood concentrations nearly identical to those found in maternal blood, emphasizes the need for careful evaluation of pregnancies in women receiving HCQ. However, only small series of HCQ-treated pregnant women have been reported, and most of these studies had no control group. We now report our experience with 133 pregnancies in women being treated with HCQ, resulting in 117 live births. Results in the HCQ group are compared with those in a control group.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3207-11
|
pubmed:dateRevised |
2006-10-6
|
pubmed:meshHeading |
pubmed-meshheading:14613284-Antirheumatic Agents,
pubmed-meshheading:14613284-Birth Weight,
pubmed-meshheading:14613284-Child,
pubmed-meshheading:14613284-Child, Preschool,
pubmed-meshheading:14613284-Female,
pubmed-meshheading:14613284-Follow-Up Studies,
pubmed-meshheading:14613284-Humans,
pubmed-meshheading:14613284-Hydroxychloroquine,
pubmed-meshheading:14613284-Infant,
pubmed-meshheading:14613284-Infant, Newborn,
pubmed-meshheading:14613284-Lupus Erythematosus, Systemic,
pubmed-meshheading:14613284-Maternal Age,
pubmed-meshheading:14613284-Maternal Exposure,
pubmed-meshheading:14613284-Maternal-Fetal Exchange,
pubmed-meshheading:14613284-Pregnancy,
pubmed-meshheading:14613284-Pregnancy, High-Risk,
pubmed-meshheading:14613284-Pregnancy Complications,
pubmed-meshheading:14613284-Pregnancy Outcome,
pubmed-meshheading:14613284-Prenatal Exposure Delayed Effects
|
pubmed:year |
2003
|
pubmed:articleTitle |
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
|
pubmed:affiliation |
Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France. nathalie.costedoat@psl.ap-hop-paris.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|